Japanese Researchers Develop Chemical Compound For Duchenne Muscular Dystrophy
This article was originally published in PharmAsia News
Executive Summary
Researchers at Osaka BioScience Research Institute and the Japanese National Center for Neurology and Psychiatry jointly developed a chemical compound targeting patients with duchenne muscular dystrophy.